August 8, 2018 10:13 AM EDTUpdated 10:40 AM

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure

Brittany Meiling

A tiny Australian biotech that experienced a very public and explosive clinical trial failure is once again in the spotlight — this time, for its ties …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure

Brittany Meiling

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

Updated: Novo Nordisk CEO to step down amid stock decline, timeline for successor unknown

Deputy FDA chief mulls shaking up PDUFA reauthorization structure

Lower attendance at cell and gene therapy conference mirrors challenged industry

FDA poses efficacy, safety questions over four cancer drugs ahead of two-day adcomm

HHS can require approval for drugmakers to apply 340B rebate models, court rules

In­sid­er trad­ing in Wash­ing­ton: NY Con­gress­man in­dict­ed for shar­ing in­side biotech tips ahead of mas­sive tri­al fail­ure

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure